Pioglitazone reduces monocyte activation in type 2 diabetes.
Pitocco D, Giubilato S, Zaccardi F, Di Stasio E, Buffon A, Biasucci LM, Liuzzo G, Crea F, Ghirlanda G.
Pitocco D, et al. Among authors: di stasio e.
Acta Diabetol. 2009 Mar;46(1):75-7. doi: 10.1007/s00592-008-0058-3. Epub 2008 Sep 27.
Acta Diabetol. 2009.
PMID: 18820825
Clinical Trial.